Aradigm

 

HomeAboutProductsTechnologiesInvestorsCareers

 

 

Leadership

About Aradigm

Business Overview

Pioneering Advancements in the Pulmonary
Pharmaceutical Industry

Aradigm's senior management team and the Board of Directors have in-depth expertise and experience in the management and oversight of public health care companies and in bringing a variety of pharmaceutical and health care products to market in the U.S. and internationally. Members of the company's Scientific Advisory Board are among the world's leading experts in pulmonary medicine and inhalation drug delivery. Together, this leadership team is pioneering important advancements in the respiratory sector of the pharmaceutical industry and positioning Aradigm as a new leader in the specialty pharmaceutical market.

 

Executive Management


 

Igor Gonda, Ph.D.
President & Chief Executive Officer
Dr. Gonda has served as President and Chief Executive Officer since August 2006, and as a director since September 2001. From December 2001 to August 2006, Dr. Gonda was the Chief Executive Officer and Managing Director of Acrux Limited, a publicly traded specialty pharmaceutical company located in Melbourne, Australia. From July 2001 to December 2001, Dr. Gonda was our Chief Scientific Officer and, from October 1995 to July 2001, was our Vice President, Research and Development. From February 1992 to September 1995, Dr. Gonda was a Senior Scientist and Group Leader at Genentech, Inc. leading inhalation development of products for severe respiratory disease. Prior to that, Dr. Gonda held academic positions at the University of Aston in Birmingham, United Kingdom, and the University of Sydney, Australia. Dr. Gonda holds a B.Sc. in Chemistry and a Ph.D. in Physical Chemistry from Leeds University, United Kingdom. Dr. Gonda was the Chairman of our Scientific Advisory Board until August 2006.

 

 

Nancy Pecota
Chief Financial Officer
Ms. Pecota has more than 20 years of experience in corporate accounting and operations management. She previously served as Chief Financial Officer for NuGEN Technologies, Inc., a life sciences tools company that provides specialty reagents to pharmaceutical and diagnostics companies. Prior to that she served as a financial consultant to early- and mid-stage life sciences companies, developing fundable business models and assessing and improving internal financial preparation and reporting processes. She has served as Vice President, Finance and Administration at Signature BioScience, Inc., a venture-backed biopharmaceutical company; and as Director, Finance and Accounting for ACLARA BioSciences, Inc., a biotechnology company. Ms. Pecota holds a Bachelor of Science in Economics from San Jose State University and was among the executives named in the San Francisco Business Times "100 Most Influential Bay Area Business Women" in 2002 and 2003.

 

 

 

 

 

Board of Directors

Virgil D. Thompson
Chairman of the Board, Aradigm Corporation;
CEO of Spinnaker Biosciences, Inc.

Frank H. Barker
Former Group Chairman, Johnson & Johnson

Igor Gonda, Ph.D.
President & Chief Executive Officer, Aradigm Corporation

Dr. John M. Siebert
Former Chairman & Chief Executive Officer, CyDex, Inc.;
Former CEO of CIMA Labs

Helen E. Short
Former Vice President of Investor Relations, Johnson & Johnson, Inc.

Scientific Advisory Board
Aradigm's Scientific Advisory Board is a highly regarded team of scientific experts who help the Company with strategic input into the development of treatments for severe respiratory disease, and in pharmaceutical development and pulmonary drug delivery in general. The group assists the company on a variety of issues related to potential product applications, product development paths and clinical testing.

Peter R. Byron, Ph.D.
Medical College of Virginia, Virginia Commonwealth University
Expertise: Aerosol Science/Pharmaceutics

Peter S. Creticos, M.D.
The Johns Hopkins University School of Medicine
Expertise: Allergy/Immunology/Asthma

Stephen J. Farr, Ph.D.
Zogenix, Inc.
Expertise: Pulmonary Delivery/Pharmaceutics

Tunde Otulana , M.D.
Boehringer Ingelheim
Expertise: Pulmonary Medicine, Regulatory Science

Adam Wanner, Ph.D.
University of Miami
Expertise: Chronic Obstructive Pulmonary Disease (COPD)

In addition to this Scientific Advisory Board, the Company also engages other scientific and medical experts to assist on issues specific to particular indications and programs.

 

CONTACT NEWS & EVENTS LEGAL SITE MAP

©2013 Aradigm Corporation. All Rights Reserved.